Skip to content

Study · In vitro (cells) · staphylococcus aureus · 2008

2 results

Increased resistance to cationic antimicrobial peptide LL-37 in methicillin-resistant strains of Staphylococcus aureus.

Ouhara K, Komatsuzawa H, Kawai T, Nishi H, Fujiwara T, Fujiue Y, Kuwabara M, Sayama K, Hashimoto K, Sugai M

The Journal of antimicrobial chemotherapy26 Mar 2008Cited by 52 (Europe PMC)

Summary

The text of this summary is not shown here, because the article license does not allow reuse. Read it at the source (opens in a new tab)

Text rights: Publisher copyright. Results still quote short attributed sentences.

Results from this study2

2 results from studies that gave the peptide. No result from this study comes from people.

  1. 01LabIn vitro (cells)Activity measurement

    In vitro, MRSA strains resistant to LL‑37 had significantly higher zeta potentials than MRSA strains susceptible to LL‑37.

    In plain wordsIn lab tests, MRSA strains that resisted LL‑37 had a higher surface charge than strains that LL‑37 could kill.

    Peptide
    LL-37
    Outcome
    IncreaseZeta potential of LL-37-resistant versus susceptible MRSA
    Study

    Staphylococcus aureusn: not reported in source

    clinical MRSA and MSSA isolates
    Comparator
    LL-37-susceptible MRSA strains
    Outcome group
    Infection and antimicrobial activity · Infection
    Studied dose
    Dose not stated

    Source sentences

    Summary
    Of the 54 randomly selected S. aureus strains, those MRSA strains resistant to LL-37 showed significantly higher zeta potentials than those susceptible to LL-37 (P < 0.05).
    1 context sentence
    Summary · context
    We examined the susceptibility of 190 clinical strains of methicillin-susceptible S. aureus (MSSA) and 304 strains of MRSA to two different classes of cationic antimicrobial peptides: LL-37 and human beta-defensin-3 (hBD3).
  2. 02LabIn vitro (cells)Activity measurement

    In vitro, resistance to LL‑37, by percentage survival or MBC, was significantly higher in highly methicillin-resistant S. aureus than in MSSA strains.

    In plain wordsIn lab tests, highly methicillin-resistant S. aureus resisted LL‑37 more than methicillin-susceptible strains.

    Peptide
    LL-37
    Outcome
    IncreaseResistance to LL-37 in highly methicillin-resistant versus MSSA strains
    Study

    Staphylococcus aureusn: not reported in source

    clinical MRSA and MSSA isolates
    Comparator
    MSSA strains
    Outcome group
    Infection and antimicrobial activity · Infection
    Studied dose
    Dose not stated

    Source sentences

    Summary
    In addition, resistance to LL-37, but not to hBD3, as determined by either percentage survival or MBC, was significantly elevated in highly methicillin-resistant strains of S. aureus when compared with MSSA strains (P < 0.01).
    1 context sentence
    Summary · context
    We examined the susceptibility of 190 clinical strains of methicillin-susceptible S. aureus (MSSA) and 304 strains of MRSA to two different classes of cationic antimicrobial peptides: LL-37 and human beta-defensin-3 (hBD3).

AI wrote and checked these results. AI can make mistakes, so check important results against the source.

Version history

PepBank keeps every version of the data on this study. Status changes from Retraction Watch, Europe PMC and Crossref are listed with their source.

  1. Version 3Current

    11 Oct 2026, 00:50 UTC

    Study results updated

  2. Version 2

    9 Oct 2026, 03:03 UTC

    Study data updated · source update from Europe PMC

  3. Version 1

    9 Oct 2026, 02:58 UTC

    First added · source update from Europe PMC

Subjects

Terms as the source lists them.

PepBank is a research reference. Talk to a doctor before you use any peptide.